AMCP to Host Webinar on Pre-Approval Communications with Payers
The Academy of Managed Care Pharmacy (AMCP) is set to host a webinar June 2 on how payers can fill [...]
COTA’s Narayanan Talks RWD in Interview with Aetion
COTA Healthcare's Life Sciences Vice President Viraj Narayanan in a recent interview with Aetion discussed how oncological real-world data can [...]
Study Finds Greater Risk of Death, Cardiac Problems Tied to Malaria Drugs Touted by Trump
A recent study suggests the malaria drugs touted by President Donald Trump as coronavirus treatments not only don't help, but [...]
JHE Editors Honor Wagstaff
The Journal of Health Economics is offering free access to the late Adam Wagstaff's contributions. Wagstaff had 24 full articles [...]
Shafrin: VBAs ‘Will Never Make Up a Majority of Reimbursement’
Healthcare economist Jason Shafrin says that while value-based agreements can be useful in a number of situations, they won't have [...]
Former FDA Chiefs Encourage Collection of RWE
Former Food and Drug Administration chiefs Mark McClellan and Scott Gottlieb urged greater incentives for the collection of real-world evidence [...]
Risks vs Rewards of Fast-Tracked Drug Evaluations
A recent article on Pharmacy Times outlines some of the risks and rewards of fast-tracking drug evaluations in the midst [...]
Haelle: More Studies Focusing on Quality of Life Needed
While an increasing number of studies are covering quality of life, there still are not enough, AHCJ's Tara Haelle writes. [...]
ICER Releases Draft Report on Ulcerative Colitis Therapies
The Institute for Clinical and Economic Review (ICER) recently released a draft evidence report on ulcerative colitis treatments. ICER is [...]
Research Finds Changes in Consumer Health Care Utilization
New research by Leede Research suggests roughly 72 percent of U.S. consumers have significantly changed their use of health care [...]
New Report Explores COVID-19 Implications for Pharma
A new FirstWord report explores how the COVID-19 could impact the pharmaceutical industry. The report, "COVID-19 implications for pharma: US [...]
Article Examines Coverage of Biosimilars
A recent article published in JAMA examines how commercial health plans cover biosimilars compared to their reference products. While Congress [...]
Study: No Confirmed Benefit of Hydroxychloroquine or Chloroquine in Treatment of COVID-19
Researchers in a recent study were unable to confirm any benefits of hydroxychloroquine or chloroquine in the treatment of COVID-19. [...]
Post Spotlights ICER’s Remdesivir Pricing Models
The authors of a recent Health Affairs blog post highlight the Institution for Clinical and Economic Review's (ICER) pricing recommendations [...]
A Look at Phlow CEO’s Track Record
STAT in a recent report takes a look at the track record of Phlow CEO Eric Edwards, who the Trump [...]
Report: High Drug Prices Could Threaten Access to Coronavirus Treatments
Pharmaceutical companies' high pricing could threaten access to potential COVID-19 treatments, The Guardian reports. Sofosbuvir, a hepatitis C drug, costs [...]
Panel Discusses Opportunity Costs, Innovative Drugs
A recent panel during Virtual ISPOR 2020 discussed how payers grapple with opportunity costs as innovative therapies hit the market. [...]
How is the QALY Performing Amid a Pandemic?
Going Below the Surface in a recent newsletter considers how the quality-adjusted life year (QALY) is holding up amid COVID-19. [...]
Value-Based vs. Fee-for-Service in the World of COVID-19
Will the COVID-19 pandemic mark a new push toward value-based payments over a fee-for-service model? Eric Weaver, executive director of [...]
Inovalon Launches New Solution to Streamline Health Plans’ Compliance with Patient Access API
Inovalon announced the launch of the Consumer Health Gateway, a new online solution aimed at helping health plans fall into [...]
Will Expanded Access to Telehealth Services Stay Put?
While the Trump administration's sweeping reimbursement changes led to expanded telehealth services and access, some are concerned about their longevity, [...]
Webinar to Outline Clinical Use Cases for Pharmacogenomic Results
The Journal of Precision Medicine and the Precision Medicine Leaders' Summits is hosting a free webinar on clinical use cases [...]
PRMA’s Lodowski Highlights 2020 Updates to ICER’s Value Assessment Framework
PRMA Consulting's Nicole Lodowski in a recent blog post outlines seven key areas that have been updated in the Institute [...]
cOAlition S Updates Criteria for Transformative Journals
cOAlition S has updated its framework guiding transformative journals to open access, The Publication Plan reports. Among the changes, cOAlition [...]
Research Finds Lower Care Costs with Increased Use of New Drugs for Treatment of Pancreatic Cancer Patients
The results of a new study by Tyme Technologies, Inc., suggests the increased use of novel drugs in the treatment [...]